Caixia Wang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Multidrug Resistant

Long Non Coding Rna

Ejection Fraction

Top Venues

Cancer research

Annals of medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peihong Wang, Yvyin Zhang, Rufang Xiang, Jie Yang, Yanli Xu, Tingfen Deng, Wei Zhou, Caixia Wang, Xinhua Xiao, Shunqing Wang
Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib. Cancer research 84 (6) (2024)
Peihong Wang, Yvyin Zhang, Rufang Xiang, Jie Yang, Yanli Xu, Tingfen Deng, Wei Zhou, Caixia Wang, Xinhua Xiao, Shunqing Wang
Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib. Cancer research (2024)
Pei-Pei Wang, Yuling Zhang, Qinghua Cai, Qingqin Long, Shiyi Pan, Wei Zhou, Tingfen Deng, Wenjian Mo, Shunqing Wang, Yuping Zhang, Caixia Wang, Cunte Chen
Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia. Annals of medicine 55 (1) (2023)
Xibao Yu, Cunte Chen, Yanyun Hu, Kehan Li, Yi-Kai Zhang, Zheng Chen, Dingrui Nie, Rili Gao, Youxue Huang, Mengjun Zhong, Caixia Wang, Shunqing Wang, Yixin Zeng, Yangqiu Li, Chengwu Zeng
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia. Cancer medicine (2023)